藥物交互作用
Diatrizoate + Empagliflozin-metformin
嚴重程度: 嚴重
Diatrizoate and Empagliflozin-metformin: major interaction.
最後更新
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
摘要
Intravascular iodinated contrast can cause acute kidney injury, which reduces metformin clearance and raises the risk of lactic acidosis. The risk is greatest in patients with impaired renal function or those given intra-arterial contrast.
用白話說明這項交互作用的意義
Diatrizoate and Empagliflozin-metformin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
為什麼會發生
Contrast-induced renal impairment reduces renal elimination of metformin, causing accumulation and lactic acidosis.
處置方式
Withhold metformin at the time of the procedure in patients with eGFR below 30, a history of liver disease, alcoholism or heart failure, or receiving intra-arterial contrast. Restart only after renal function has been re-checked and found stable, usually after 48 hours.
可向藥師詢問的問題
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Empagliflozin-metformin 的其他交互作用
常見問題
Can I take Diatrizoate with Empagliflozin-metformin?
MediHelp rates the interaction as major. Diatrizoate and Empagliflozin-metformin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Intravascular iodinated contrast can cause acute kidney injury, which reduces metformin clearance and raises the risk of lactic acidosis. The risk is greatest in patients with impaired renal function or those given intra-arterial contrast.
How serious is the interaction between Diatrizoate and Empagliflozin-metformin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Withhold metformin at the time of the procedure in patients with eGFR below 30, a history of liver disease, alcoholism or heart failure, or receiving intra-arterial contrast. Restart only after renal function has been re-checked and found stable, usually after 48 hours.
What other medicines interact with Empagliflozin-metformin?
MediHelp also lists interactions of Empagliflozin-metformin with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diazoxide. The full list is on the Empagliflozin-metformin page.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
